Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Sale of product	$ 3,112,165	$ 2,434,808	$ 6,201,700	$ 5,242,249
Cost of product	1,269,552	1,034,278	2,579,051	2,164,976
Gross profit	1,842,613	1,400,530	3,622,649	3,077,273
Operating costs and expenses:
Salaries and contract labor	944,179	801,972	1,919,361	1,735,221
General, administrative and consulting	943,870	863,025	1,771,852	1,776,148
Research and development	183,024	87,642	307,468	294,056
Total operating expenses	2,071,073	1,752,639	3,998,681	3,805,425
Net operating loss	(228,460)	(352,109)	(376,032)	(728,152)
Other income (expense):
Other income	37,518	225,768	100,930	2,028,568
Interest income	9,856	680	28,942	725
Interest expense	(82,216)	(146,387)	(165,196)	(318,144)
Total other income (expense)	(34,842)	80,061	(35,324)	1,711,149
Net income (loss)	$ (263,302)	$ (272,048)	$ (411,356)	$ 982,997
Net loss per common share - basic: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Net loss per common share - diluted: (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding - basic (in shares)	517,926,610	510,499,497	516,746,718	506,985,962
Weighted average common shares outstanding - diluted (in shares)	517,926,610	510,499,497	516,746,718	512,569,114